Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Phosphorylated Y1357 is increased in HER2/neu (v-erb-b2 erythroblastic leukemia viral oncogene homolog 2) mammary tumor epithelia and is required to modulate AIB1/SRC-3 coactivation of estrogen receptor alpha (ERalpha), progesterone receptor B, NF-kappaB, and AP-1-dependent promoters.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP565742.RACMcnrfk8zly6J2mByToDq-kvSD4aC3t4W_phKJ7V4mI130_assertion description "[Phosphorylated Y1357 is increased in HER2/neu (v-erb-b2 erythroblastic leukemia viral oncogene homolog 2) mammary tumor epithelia and is required to modulate AIB1/SRC-3 coactivation of estrogen receptor alpha (ERalpha), progesterone receptor B, NF-kappaB, and AP-1-dependent promoters.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP565742.RACMcnrfk8zly6J2mByToDq-kvSD4aC3t4W_phKJ7V4mI130_provenance.
• NP547768.RAXmZGWMU4Msrz0YFChMhB2W-PFeP1iqRuqhWPuQtYHnU130_assertion description "[Phosphorylated Y1357 is increased in HER2/neu (v-erb-b2 erythroblastic leukemia viral oncogene homolog 2) mammary tumor epithelia and is required to modulate AIB1/SRC-3 coactivation of estrogen receptor alpha (ERalpha), progesterone receptor B, NF-kappaB, and AP-1-dependent promoters.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP547768.RAXmZGWMU4Msrz0YFChMhB2W-PFeP1iqRuqhWPuQtYHnU130_provenance.
• NP927577.RAvwf2-mBUHgzIdRYFSu3hvFPpR97iNvAa7--fGzYGP4Y130_assertion description "[Phosphorylated Y1357 is increased in HER2/neu (v-erb-b2 erythroblastic leukemia viral oncogene homolog 2) mammary tumor epithelia and is required to modulate AIB1/SRC-3 coactivation of estrogen receptor alpha (ERalpha), progesterone receptor B, NF-kappaB, and AP-1-dependent promoters.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP927577.RAvwf2-mBUHgzIdRYFSu3hvFPpR97iNvAa7--fGzYGP4Y130_provenance.
• NP156004.RAWm57LymA7IiH1JuBzwd1uiydNCthxcqBcqxetqU0x-s130_assertion description "[Phosphorylated Y1357 is increased in HER2/neu (v-erb-b2 erythroblastic leukemia viral oncogene homolog 2) mammary tumor epithelia and is required to modulate AIB1/SRC-3 coactivation of estrogen receptor alpha (ERalpha), progesterone receptor B, NF-kappaB, and AP-1-dependent promoters.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP156004.RAWm57LymA7IiH1JuBzwd1uiydNCthxcqBcqxetqU0x-s130_provenance.
• NP490366.RAmuQqD1hcAgqtr-weDzCZpExEZBqxpvvxi4GEBfi0fwU130_assertion description "[Phosphorylated Y1357 is increased in HER2/neu (v-erb-b2 erythroblastic leukemia viral oncogene homolog 2) mammary tumor epithelia and is required to modulate AIB1/SRC-3 coactivation of estrogen receptor alpha (ERalpha), progesterone receptor B, NF-kappaB, and AP-1-dependent promoters.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP490366.RAmuQqD1hcAgqtr-weDzCZpExEZBqxpvvxi4GEBfi0fwU130_provenance.
• NP721632.RAaWcmHePVllKynqxMgxJ1Wr9pDoRMJ_6L-JWH96JGPOw130_assertion description "[Phosphorylated Y1357 is increased in HER2/neu (v-erb-b2 erythroblastic leukemia viral oncogene homolog 2) mammary tumor epithelia and is required to modulate AIB1/SRC-3 coactivation of estrogen receptor alpha (ERalpha), progesterone receptor B, NF-kappaB, and AP-1-dependent promoters.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP721632.RAaWcmHePVllKynqxMgxJ1Wr9pDoRMJ_6L-JWH96JGPOw130_provenance.
• NP379002.RAQoIa2iPGhhzpXvelGyNPnsAETQW6ixZ4NCUmLTn6-qw130_assertion description "[Phosphorylated Y1357 is increased in HER2/neu (v-erb-b2 erythroblastic leukemia viral oncogene homolog 2) mammary tumor epithelia and is required to modulate AIB1/SRC-3 coactivation of estrogen receptor alpha (ERalpha), progesterone receptor B, NF-kappaB, and AP-1-dependent promoters.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP379002.RAQoIa2iPGhhzpXvelGyNPnsAETQW6ixZ4NCUmLTn6-qw130_provenance.
• NP914753.RAz_0pxOY3zRp1RBLatcZr63C3aZXSrGG6Lehf_UQRois130_assertion description "[Phosphorylated Y1357 is increased in HER2/neu (v-erb-b2 erythroblastic leukemia viral oncogene homolog 2) mammary tumor epithelia and is required to modulate AIB1/SRC-3 coactivation of estrogen receptor alpha (ERalpha), progesterone receptor B, NF-kappaB, and AP-1-dependent promoters.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP914753.RAz_0pxOY3zRp1RBLatcZr63C3aZXSrGG6Lehf_UQRois130_provenance.
• NP852004.RA_s4tYf07lrd3mhlRCM6C2m3C6jDJ9j--WZ0bSN77oq8130_assertion description "[Phosphorylated Y1357 is increased in HER2/neu (v-erb-b2 erythroblastic leukemia viral oncogene homolog 2) mammary tumor epithelia and is required to modulate AIB1/SRC-3 coactivation of estrogen receptor alpha (ERalpha), progesterone receptor B, NF-kappaB, and AP-1-dependent promoters.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP852004.RA_s4tYf07lrd3mhlRCM6C2m3C6jDJ9j--WZ0bSN77oq8130_provenance.
• NP792848.RAW0I6JLmGLNzEF6gUK33fIxQT6URDXCuZxgz4NBJKcXU130_assertion description "[Phosphorylated Y1357 is increased in HER2/neu (v-erb-b2 erythroblastic leukemia viral oncogene homolog 2) mammary tumor epithelia and is required to modulate AIB1/SRC-3 coactivation of estrogen receptor alpha (ERalpha), progesterone receptor B, NF-kappaB, and AP-1-dependent promoters.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP792848.RAW0I6JLmGLNzEF6gUK33fIxQT6URDXCuZxgz4NBJKcXU130_provenance.
• NP966403.RAVnMnu0J3xDlWvZGyP9ZtJxXAWsyWwDq7a53CCqWPBIE130_assertion description "[Phosphorylated Y1357 is increased in HER2/neu (v-erb-b2 erythroblastic leukemia viral oncogene homolog 2) mammary tumor epithelia and is required to modulate AIB1/SRC-3 coactivation of estrogen receptor alpha (ERalpha), progesterone receptor B, NF-kappaB, and AP-1-dependent promoters.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP966403.RAVnMnu0J3xDlWvZGyP9ZtJxXAWsyWwDq7a53CCqWPBIE130_provenance.
• NP864082.RAG6GD5OnMAjPWcJFA36KLQiJD4TsDN8qRFEWH0dJ2b7k130_assertion description "[Phosphorylated Y1357 is increased in HER2/neu (v-erb-b2 erythroblastic leukemia viral oncogene homolog 2) mammary tumor epithelia and is required to modulate AIB1/SRC-3 coactivation of estrogen receptor alpha (ERalpha), progesterone receptor B, NF-kappaB, and AP-1-dependent promoters.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP864082.RAG6GD5OnMAjPWcJFA36KLQiJD4TsDN8qRFEWH0dJ2b7k130_provenance.
• NP792712.RAvz-LfeBVh8pRrPWLi9sRQrLo2hfc0hcFDRhjhcswLKM130_assertion description "[Phosphorylated Y1357 is increased in HER2/neu (v-erb-b2 erythroblastic leukemia viral oncogene homolog 2) mammary tumor epithelia and is required to modulate AIB1/SRC-3 coactivation of estrogen receptor alpha (ERalpha), progesterone receptor B, NF-kappaB, and AP-1-dependent promoters.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP792712.RAvz-LfeBVh8pRrPWLi9sRQrLo2hfc0hcFDRhjhcswLKM130_provenance.
• NP691127.RATBisjXU9JpvwS1W_FiqLQCzFxSLXNVIFuKslDtVNLzg130_assertion description "[Phosphorylated Y1357 is increased in HER2/neu (v-erb-b2 erythroblastic leukemia viral oncogene homolog 2) mammary tumor epithelia and is required to modulate AIB1/SRC-3 coactivation of estrogen receptor alpha (ERalpha), progesterone receptor B, NF-kappaB, and AP-1-dependent promoters.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP691127.RATBisjXU9JpvwS1W_FiqLQCzFxSLXNVIFuKslDtVNLzg130_provenance.
• NP966478.RArI99RFv44wO87G_0ncc1RfrFG2rC309FqGHprzLOEjY130_assertion description "[Phosphorylated Y1357 is increased in HER2/neu (v-erb-b2 erythroblastic leukemia viral oncogene homolog 2) mammary tumor epithelia and is required to modulate AIB1/SRC-3 coactivation of estrogen receptor alpha (ERalpha), progesterone receptor B, NF-kappaB, and AP-1-dependent promoters.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP966478.RArI99RFv44wO87G_0ncc1RfrFG2rC309FqGHprzLOEjY130_provenance.
• NP691114.RAOl04URZ6B5fgoUTqpz6pGQh0GN4-jmfuFIZo_rBfk2w130_assertion description "[Phosphorylated Y1357 is increased in HER2/neu (v-erb-b2 erythroblastic leukemia viral oncogene homolog 2) mammary tumor epithelia and is required to modulate AIB1/SRC-3 coactivation of estrogen receptor alpha (ERalpha), progesterone receptor B, NF-kappaB, and AP-1-dependent promoters.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP691114.RAOl04URZ6B5fgoUTqpz6pGQh0GN4-jmfuFIZo_rBfk2w130_provenance.
• NP691118.RAFAgtxK_TDiUhB3Sn6CzOqBO4pBUXkW6f9GvW-MFcfkE130_assertion description "[Phosphorylated Y1357 is increased in HER2/neu (v-erb-b2 erythroblastic leukemia viral oncogene homolog 2) mammary tumor epithelia and is required to modulate AIB1/SRC-3 coactivation of estrogen receptor alpha (ERalpha), progesterone receptor B, NF-kappaB, and AP-1-dependent promoters.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP691118.RAFAgtxK_TDiUhB3Sn6CzOqBO4pBUXkW6f9GvW-MFcfkE130_provenance.
• NP691121.RAMPZF04MlO-hYzx9eFDZduFwhnkS-I7Y1qRTbzuO3WG4130_assertion description "[Phosphorylated Y1357 is increased in HER2/neu (v-erb-b2 erythroblastic leukemia viral oncogene homolog 2) mammary tumor epithelia and is required to modulate AIB1/SRC-3 coactivation of estrogen receptor alpha (ERalpha), progesterone receptor B, NF-kappaB, and AP-1-dependent promoters.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP691121.RAMPZF04MlO-hYzx9eFDZduFwhnkS-I7Y1qRTbzuO3WG4130_provenance.
• NP691124.RAO1GMtHptXLChODFJAf-9eeijGqpA6BMVOrM84xYte60130_assertion description "[Phosphorylated Y1357 is increased in HER2/neu (v-erb-b2 erythroblastic leukemia viral oncogene homolog 2) mammary tumor epithelia and is required to modulate AIB1/SRC-3 coactivation of estrogen receptor alpha (ERalpha), progesterone receptor B, NF-kappaB, and AP-1-dependent promoters.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP691124.RAO1GMtHptXLChODFJAf-9eeijGqpA6BMVOrM84xYte60130_provenance.
• NP691123.RAyNcluI_weJM24siV13WYWiwSeV-BDwAMf1wVVCHVwjE130_assertion description "[Phosphorylated Y1357 is increased in HER2/neu (v-erb-b2 erythroblastic leukemia viral oncogene homolog 2) mammary tumor epithelia and is required to modulate AIB1/SRC-3 coactivation of estrogen receptor alpha (ERalpha), progesterone receptor B, NF-kappaB, and AP-1-dependent promoters.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP691123.RAyNcluI_weJM24siV13WYWiwSeV-BDwAMf1wVVCHVwjE130_provenance.